Loading page…
Healthcare
Abbott Laboratories is assigned an AlphaScore of 53/100 in the Healthcare sector as of the October 11, 2026 snapshot. Fundamentals include a gross margin of 56.42% and a conservative debt-to-equity ratio of 0.25. A key strength is its low debt-to-equity ratio, indicating a healthy and stable balance sheet structure. A distinct risk is its sluggish revenue growth rate of 5.67% alongside a moderate return on equity (ROE) of 12.51%. Evidence is limited to the supplied record.
Written 11/10/2026, 00:23:45 UTC · Snapshot 11/10/2026